Globus Medical Inc. Files Definitive Proxy Statement

TL;DR

<b>Globus Medical Inc. has filed its Definitive Proxy Statement for the fiscal year ending December 31, 2023, detailing executive compensation and board matters.</b>

AI Summary

GLOBUS MEDICAL INC (GMED) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Globus Medical Inc. filed a Definitive Proxy Statement (DEF 14A) on April 26, 2024. The filing covers the fiscal year ending December 31, 2023. The company's principal executive offices are located at 2560 General Armistead Avenue, Audubon, PA 19403. The filing includes information related to executive compensation and board member activities. Specific details on equity compensation for PEO and Non-PEO NEO members are presented for fiscal years 2023 and 2022.

Why It Matters

For investors and stakeholders tracking GLOBUS MEDICAL INC, this filing contains several important signals. This DEF 14A filing provides shareholders with crucial information regarding executive compensation packages and the performance of board members, enabling informed voting decisions. The detailed breakdown of equity awards and their valuations for key executives offers transparency into the company's incentive structures and potential future dilution.

Risk Assessment

Risk Level: low — GLOBUS MEDICAL INC shows low risk based on this filing. The filing is a routine DEF 14A, which is standard for publicly traded companies and does not contain new material financial information or significant operational changes.

Analyst Insight

Review the executive compensation details and any shareholder proposals to understand management's incentives and potential governance changes.

Key Numbers

• 2023-12-31 — Fiscal Year End (Conformed Period of Report)
• 2024-04-26 — Filing Date (Filed as of Date)
• 21 — Public Document Count (Document Count)

Key Players & Entities

• GLOBUS MEDICAL INC (company) — Filer
• 2560 GENERAL ARMISTEAD AVENUE (address) — Business Address
• AUDUBON (location) — Business Address City
• PA (location) — Business Address State
• 19403 (postal_code) — Business Address Zip
• Daniel Scavilla (person) — Member
• David Demski (person) — Member

FAQ

Industry Context

Globus Medical Inc. operates in the surgical and medical instruments and apparatus industry.

Regulatory Implications

The filing is a DEF 14A, which is a standard SEC filing for companies holding annual shareholder meetings to solicit proxies.

What Investors Should Do

1. Review the compensation details for named executive officers (NEOs).
2. Examine any proposals being put forth for shareholder vote.
3. Check for any changes in board composition or director nominees.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a routine disclosure for the annual shareholder meeting, and does not represent a change from previous filings of this type.

Filing Documents

• gmed-20231231xdef14a.htm (DEF 14A) — 1944KB
• gmed-20231231xdef14ag001.jpg (GRAPHIC) — 165KB
• gmed-20231231xdef14ag002.jpg (GRAPHIC) — 3KB
• gmed-20231231xdef14ag003.jpg (GRAPHIC) — 65KB
• gmed-20231231xdef14ag004.jpg (GRAPHIC) — 51KB
• gmed-20231231xdef14ag005.jpg (GRAPHIC) — 54KB
• gmed-20231231xdef14ag006.jpg (GRAPHIC) — 87KB
• gmed-20231231xdef14ag007.jpg (GRAPHIC) — 92KB
• 0001562762-24-000102.txt (&nbsp;) — 3952KB
• gmed-20231231.xsd (EX-101.SCH) — 6KB
• gmed-20231231_def.xml (EX-101.DEF) — 5KB
• gmed-20231231_lab.xml (EX-101.LAB) — 34KB
• gmed-20231231_pre.xml (EX-101.PRE) — 21KB
• gmed-20231231xdef14a_htm.xml (XML) — 198KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 50 TRANSACTIONS WITH RELATED PERSONS 52 STOCKHOLDER PROPOSALS 53 ELECTRONIC ACCESS TO PROXY MATERIALS AND ANNUAL REPORT 54 HOUSEHOLDING OF PROXY MATERIALS 54 OTHER MATTERS 55 3 GLOBUS MEDICAL, INC. Valley Forge Business Center 2560 General Armistead Avenue Audubon, PA 19403 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS GENERAL INFORMATION We are providing these proxy materials in connection with the solicitation by the Board of Directors of Globus Medical, Inc., a Delaware corporation (the "Company," "Globus," "Globus Medical," "our," "we," or "us"), of proxies to be voted at our 2024 Annual Meeting of Stockholders (the "Annual Meeting") and at any adjournments or postponements thereof. The Annual Meeting will begin at 6:00 p.m., Eastern Time, on Wednesday, June 5, 2024 at our corporate headquarters located at 2560 General Armistead Avenue, Audubon, Pennsylvania 19403. The "proxy materials" include this Proxy Statement, our Annual Report for the year ended December 31, 2023 (including our annual report on Form 10-K) and, if you are receiving printed copies of the proxy materials by mail, the proxy card. We are making these proxy materials available to our stockholders electronically via the Internet beginning on April 26, 2024. Accordingly, we are mailing to our stockholders of record and beneficial owners a Notice of Internet Availability of Proxy Materials containing instructions on how to access the proxy materials via the Internet and how to vote online. As a result, you will not receive a paper copy of the proxy materials unless you request one. All stockholders are able to access the proxy materials on a website referred to in the Notice of Internet Availability of Proxy Materials and in this Proxy Statement, and to request to receive a set of the proxy materials by mail or electronically, in either case free of charge. If you would like to receive

View Full Filing

View this DEF 14A filing on SEC EDGAR